Back
Climb Bio, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
73
CLYM
Climb Bio, Inc.
Last Price:
$5.63
Seasonality Move:
38.16%
7 Day Trial
ALL ACCESS PASS
$
7
Climb Bio, Inc. Stock Forecast
-
Over the next 52 weeks, Climb Bio, Inc. has on average historically risen by 31.5% based on the past 4 years of stock performance.
-
Climb Bio, Inc. has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%
-
Is Climb Bio, Inc. Stock Undervalued?The current Climb Bio, Inc. [CLYM] share price is $5.50. The Score for CLYM is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
-
CLYM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
Will Climb Bio, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Climb Bio, Inc. has on average historically risen by 31.5% based on the past 4 years of stock performance.
Climb Bio, Inc. Stock Rating
Buy
73
Climb Bio, Inc. (CLYM)
is a Buy
Is Climb Bio, Inc. overpriced?
-
Climb Bio, Inc. has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%
Climb Bio, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
climbbio.com
52-Week Data
52-Week High:
6.22
52-Week Low:
1.05
Prediction Charts
Market Cap:
375M
Price in USD:
5.50
Volume:
347.8K
Beta:
-0.16
Technical Analysis
SMA50:
4.27
SMA100:
3.10
SMA200:
2.34
52-Wk Change:
259.48%
Stock Predictions
-
Is Climb Bio, Inc. stock public?Yes, Climb Bio, Inc. is a publicly traded company.
-
What is the Climb Bio, Inc. stock quote today?The Climb Bio, Inc. stock price is 5.50 USD today.
-
How to buy Climb Bio, Inc. stock online?You can buy Climb Bio, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-29 | 5.16 | 4.78 | 5.27 | 4.68 |
| Jan-30 | 4.73 | 4.47 | 4.91 | 4.41 |
| Feb-2 | 4.45 | 4.73 | 4.75 | 4.45 |
| Feb-3 | 4.72 | 5.15 | 5.17 | 4.72 |
| Feb-4 | 5.18 | 5.05 | 5.60 | 5.00 |
| Feb-5 | 4.88 | 4.65 | 5.11 | 4.63 |
| Feb-6 | 4.72 | 5.44 | 5.45 | 4.70 |
| Feb-9 | 5.50 | 5.77 | 5.81 | 5.24 |
| Feb-10 | 5.70 | 5.50 | 5.86 | 5.31 |
| Feb-11 | 5.50 | 5.56 | 5.59 | 5.08 |
| Feb-12 | 5.56 | 5.27 | 5.56 | 5.06 |
| Feb-13 | 5.63 | 5.67 | 6.22 | 5.56 |
| Feb-17 | 5.64 | 5.61 | 5.78 | 5.16 |
| Feb-18 | 5.60 | 5.50 | 5.60 | 5.37 |
Climb Bio, Inc. Earnings
Climb Bio, Inc. Earnings Report: Per Share Climb Bio, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Climb Bio, Inc. Forecast Revenue Growth
Climb Bio, Inc. Stock Analysis: Historical quarterly revenues per share for Climb Bio, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.07 per share, and a decrease next year of $0.27 per share.
* Climb Bio, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.